Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CM512 in Chronic Rhinosinusitis With Nasal Polyps
NCT07807826Phase 3Not yet recruiting
- Sponsor
- Keymed Biosciences
- Start
- Oct 2026
- Primary completion
- Nov 2027
- Countries
- 1
01
Overview
A Phase 3 trial of CM512 in chronic rhinosinusitis with nasal polyposis (CRSwNP), sponsored by Keymed Biosciences. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
CM512
03
Conditions
chronic rhinosinusitis with nasal polyposis (CRSwNP)
Beyond the preview
Go deeper on NCT07807826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07807826.